Likewise, Tzeng et al. found that administration of IFNα (as well as other DC maturation stimuli) after treatment of melanoma-bearing mice with a combination therapy that mediates tumor Ag release enhanced the cross-presentation and cross-priming activities of CD8α+ DC in tumor-draining lymph nodes (133). This evidence concerns the gene CD8A and neoplasm.